News

The Almac Group has announced a collaboration with cloud-based solution provider Exostar.

Specimatch announced the launch of its web-based software service for cancer patients and oncologists.

PPD has announced an expansion of its stability sample storage capacity and capabilities.

Spare a thought for your Scandinavian colleagues who are running CROs

The Alliance for Clinical Research Excellence and Safety (ACRES) has partnered with the British Standards Institution (BSI) to launch a multi-stakeholder global working party.

The advancement of technology has allowed for new solutions to become available in all areas of clinical trials. Patient Recruitment Systems are no exception as they can be used to improve the trial process by optimizing protocols, selecting high potential sites and enabling more studies.

The FDA Amendment Act is on its way toward implementation at years’ end. We reveal the facts on clinical trial disclosure for compliance with these new requirements.

With much happening in the clinical trials industry during 2016, Moe Alsumidaie looks back at some of the innovations that took place. He also looks forward to what the industry can bring us in 2017.

Over the last decade, many initiatives sponsored by various entities, including academic and clinical research centers have focused on efforts to streamline clinical trial eligibility and data collection. Oncology trial design is no exception as endpoints and eligibility criteria have also changed with the value of the data generated in early phase studies.

ERT has announced the acquisition of Exco InTouch.

A European research hospital has selected OmniComm’s TrialMaster electronic data capture (EDC) technology to integrate privacy-protected patient data from the hospital’s electronic health records.

The Dentistry School of the University of Istanbul, Turkey has joined Clinerion’s Patient Recruitment System platform.

Almac Clinical Technologies, part of the Almac Group, announced a partnership with inVentiv Health.

CRIO will participate in Medidata’s new eConnect Partner program for integration with its clinical cloud.

ERT announced an upgrade to its flagship platform for centralized respiratory clinical trials, MasterScope.

Most clinical trial activity for Phase III trials takes place in the traditional North American and European markets.

In a comparison study of source data review (SDV) methods, this new process demonstrates the value of using well-planned data visualization tools to provide better quality oversight versus remote eCRF review or onsite SDV.

A new SaaS platform for clinical trials, soon available to all pharma companies, aims to automate clinical supply, improve patient compliance and enable better medication adherence.